These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7657295

  • 1. The growth inhibitory effects of vitamins K and their actions on gene expression.
    Wang Z, Wang M, Finn F, Carr BI.
    Hepatology; 1995 Sep; 22(3):876-82. PubMed ID: 7657295
    [Abstract] [Full Text] [Related]

  • 2. Growth control and gene expression in a new hepatocellular carcinoma cell line, Hep40: inhibitory actions of vitamin K.
    Bouzahzah B, Nishikawa Y, Simon D, Carr BI.
    J Cell Physiol; 1995 Dec; 165(3):459-67. PubMed ID: 7593224
    [Abstract] [Full Text] [Related]

  • 3. Antitumor effects of vitamins K1, K2 and K3 on hepatocellular carcinoma in vitro and in vivo.
    Hitomi M, Yokoyama F, Kita Y, Nonomura T, Masaki T, Yoshiji H, Inoue H, Kinekawa F, Kurokohchi K, Uchida N, Watanabe S, Kuriyama S.
    Int J Oncol; 2005 Mar; 26(3):713-20. PubMed ID: 15703828
    [Abstract] [Full Text] [Related]

  • 4. Vitamin K2 inhibits the growth of hepatocellular carcinoma via decrease of des-gamma-carboxy prothrombin.
    Ma M, Qu XJ, Mu GY, Chen MH, Cheng YN, Kokudo N, Tang W, Cui SX.
    Chemotherapy; 2009 Mar; 55(1):28-35. PubMed ID: 18974646
    [Abstract] [Full Text] [Related]

  • 5. Vitamins K2, K3 and K5 exert in vivo antitumor effects on hepatocellular carcinoma by regulating the expression of G1 phase-related cell cycle molecules.
    Kuriyama S, Hitomi M, Yoshiji H, Nonomura T, Tsujimoto T, Mitoro A, Akahane T, Ogawa M, Nakai S, Deguchi A, Masaki T, Uchida N.
    Int J Oncol; 2005 Aug; 27(2):505-11. PubMed ID: 16010434
    [Abstract] [Full Text] [Related]

  • 6. Attenuation of transforming growth factor beta-induced growth inhibition in human hepatocellular carcinoma cell lines by cyclin D1 overexpression.
    Jong HS, Lee HS, Kim TY, Im YH, Park JW, Kim NK, Bang YJ.
    Biochem Biophys Res Commun; 2002 Mar 29; 292(2):383-9. PubMed ID: 11906173
    [Abstract] [Full Text] [Related]

  • 7. Measurement of immunoreactive prothrombin, des-gamma-carboxy prothrombin, and vitamin K in human liver tissues: overproduction of immunoreactive prothrombin in hepatocellular carcinoma.
    Ono M, Ohta H, Ohhira M, Sekiya C, Namiki M.
    Am J Gastroenterol; 1990 Sep 29; 85(9):1149-54. PubMed ID: 1697141
    [Abstract] [Full Text] [Related]

  • 8. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
    Ozaki I, Zhang H, Mizuta T, Ide Y, Eguchi Y, Yasutake T, Sakamaki T, Pestell RG, Yamamoto K.
    Clin Cancer Res; 2007 Apr 01; 13(7):2236-45. PubMed ID: 17404108
    [Abstract] [Full Text] [Related]

  • 9. Mechanism of the abnormal vitamin K-dependent gamma-carboxylation process in human hepatocellular carcinomas.
    Huisse MG, Leclercq M, Belghiti J, Flejou JF, Suttie JW, Bezeaud A, Stafford DW, Guillin MC.
    Cancer; 1994 Sep 01; 74(5):1533-41. PubMed ID: 7520347
    [Abstract] [Full Text] [Related]

  • 10. K vitamins, PTP antagonism, and cell growth arrest.
    Carr BI, Wang Z, Kar S.
    J Cell Physiol; 2002 Dec 01; 193(3):263-74. PubMed ID: 12384979
    [Abstract] [Full Text] [Related]

  • 11. Involvement of interferon regulatory factor 1 and S100C/A11 in growth inhibition by transforming growth factor beta 1 in human hepatocellular carcinoma cells.
    Miyazaki M, Sakaguchi M, Akiyama I, Sakaguchi Y, Nagamori S, Huh NH.
    Cancer Res; 2004 Jun 15; 64(12):4155-61. PubMed ID: 15205326
    [Abstract] [Full Text] [Related]

  • 12. The gene expression level of transforming growth factor-beta (TGF-beta) as a biological prognostic marker of hepatocellular carcinoma.
    Ikeguchi M, Iwamoto A, Taniguchi K, Katano K, Hirooka Y.
    J Exp Clin Cancer Res; 2005 Sep 15; 24(3):415-21. PubMed ID: 16270528
    [Abstract] [Full Text] [Related]

  • 13. Des-gamma-carboxy prothrombin increases the expression of angiogenic factors in human hepatocellular carcinoma cells.
    Gao FJ, Cui SX, Chen MH, Cheng YN, Sun LR, Ward SG, Kokudo N, Tang W, Qu XJ.
    Life Sci; 2008 Dec 05; 83(23-24):815-20. PubMed ID: 18976674
    [Abstract] [Full Text] [Related]

  • 14. Levels of vitamin K, immunoreactive prothrombin, des-gamma-carboxy prothrombin and gamma-glutamyl carboxylase activity in hepatocellular carcinoma tissue.
    Yamagata H, Nakanishi T, Furukawa M, Okuda H, Obata H.
    J Gastroenterol Hepatol; 1995 Dec 05; 10(1):8-13. PubMed ID: 7620113
    [Abstract] [Full Text] [Related]

  • 15. Des-gamma-carboxy prothrombin in cancer and non-cancer liver tissue of patients with hepatocellular carcinoma.
    Tang W, Miki K, Kokudo N, Sugawara Y, Imamura H, Minagawa M, Yuan LW, Ohnishi S, Makuuchi M.
    Int J Oncol; 2003 May 05; 22(5):969-75. PubMed ID: 12684661
    [Abstract] [Full Text] [Related]

  • 16. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
    Ogawa M, Nakai S, Deguchi A, Nonomura T, Masaki T, Uchida N, Yoshiji H, Kuriyama S.
    Int J Oncol; 2007 Aug 05; 31(2):323-31. PubMed ID: 17611688
    [Abstract] [Full Text] [Related]

  • 17. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
    Sugano Y, Matsuzaki K, Tahashi Y, Furukawa F, Mori S, Yamagata H, Yoshida K, Matsushita M, Nishizawa M, Fujisawa J, Inoue K.
    Oncogene; 2003 Apr 17; 22(15):2309-21. PubMed ID: 12700666
    [Abstract] [Full Text] [Related]

  • 18. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
    Matsuzaki K, Date M, Furukawa F, Tahashi Y, Matsushita M, Sugano Y, Yamashiki N, Nakagawa T, Seki T, Nishizawa M, Fujisawa J, Inoue K.
    Hepatology; 2000 Aug 17; 32(2):218-27. PubMed ID: 10915727
    [Abstract] [Full Text] [Related]

  • 19. Sensitivity to transforming growth factor beta 1-induced growth arrest is common in human squamous cell carcinoma cell lines: c-MYC down-regulation and p21waf1 induction are important early events.
    Malliri A, Yeudall WA, Nikolic M, Crouch DH, Parkinson EK, Ozanne B.
    Cell Growth Differ; 1996 Oct 17; 7(10):1291-304. PubMed ID: 8891333
    [Abstract] [Full Text] [Related]

  • 20. Transforming growth factor-beta 1 induces apoptosis through down-regulation of c-myc gene and overexpression of p27Kip1 protein in cervical carcinoma.
    Kim JW, Kim HS, Kim IK, Kim MR, Cho EY, Kim HK, Lee JM, Namkoong SE.
    Gynecol Oncol; 1998 Jun 17; 69(3):230-6. PubMed ID: 9648593
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.